Tenaya Therapeutics, Inc. (TNYA) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TNYA Revenue Growth
TNYA Revenue Analysis (2019–2025)
As of May 8, 2026, Tenaya Therapeutics, Inc. (TNYA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, TNYA's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including SGMO (-37.1% YoY), NTLA (+16.9% YoY), and BEAM (+108.0% YoY). Compare TNYA vs SGMO →
TNYA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TNYACurrent | $0 | - | - | - | |
 SGMO | $58M | -37.1% | -10.8% | -179.9% | |
 NTLA | $68M | +16.9% | +3.1% | -651.7% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% |
TNYA Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-8,436,000 | - | $-93,331,000 | - |
| 2024 | $0 | - | $-8,468,000 | - | $-115,948,000 | - |
| 2023 | $0 | - | $-8,687,000 | - | $-131,193,000 | - |
| 2022 | $0 | - | $-8,713,000 | - | $-125,621,000 | - |
| 2021 | $0 | - | $-4,025,000 | - | $-72,806,000 | - |
| 2020 | $0 | - | $-2,483,000 | - | $-38,912,000 | - |
| 2019 | $0 | - | $-1,989,000 | - | $-27,712,000 | - |
See TNYA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TNYA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TNYA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTNYA — Frequently Asked Questions
Quick answers to the most common questions about buying TNYA stock.
Is TNYA's revenue growth accelerating or slowing?
TNYA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TNYA's long-term revenue growth rate?
Tenaya Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TNYA's revenue distributed by segment?
TNYA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.